China Medical System Holdings Ltd
00867
Company Profile
Business description
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
Contact
510 King’s Road
Unit 2106, 21st Floor, Island Place Tower
North Point
Hong Kong
HKGT: +852 23697678
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
6,415
Stocks News & Analysis
stocks
Wide moat share remains cheap despite rising costs
Higher costs weigh on profits but stronger sales trends support long term outlook.
stocks
Fair value upgrade for ASX listed fast food chain
Earnings beat lifts forecasts but long term growth questions remain.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
We’re expecting another beat-and-raise quarter, while watching the roadmap and discussions of its financing and partnership deals.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,365.70 | 41.20 | 0.44% |
| CAC 40 | 8,453.01 | 31.42 | -0.37% |
| DAX 40 | 26,106.60 | 29.96 | -0.11% |
| Dow JONES (US) | 53,417.16 | 140.15 | 0.26% |
| FTSE 100 | 10,854.32 | 37.76 | 0.35% |
| HKSE | 25,453.19 | 64.14 | -0.25% |
| NASDAQ | 25,980.19 | 200.27 | -0.76% |
| Nikkei 225 | 65,766.93 | 238.84 | 0.36% |
| NZX 50 Index | 14,002.21 | 120.33 | 0.87% |
| S&P 500 | 7,652.86 | 21.51 | -0.28% |
| S&P/ASX 200 | 9,157.80 | 47.50 | 0.52% |
| SSE Composite Index | 3,876.38 | 5.63 | -0.14% |